Israel Englander’s Privia Health PRVA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-35,000
Closed -$684K 6297
2024
Q4
$684K Buy
+35,000
New +$694K ﹤0.01% 4500
2022
Q2
Sell
-131,200
Closed -$3.51M 7384
2022
Q1
$3.51M Buy
+131,200
New +$3.1M ﹤0.01% 3329

Other funds holding PRVA

Israel Englander's PRVA Position: Q2 2026 in Review

Israel Englander reduced its Privia Health (PRVA) stake by 62% in Q2 2026, selling an estimated $10.3M and leaving 268,324 shares worth $6.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2682.

Israel Englander first reported a position in PRVA in Q2 2021 and has held it in 21 quarters since. The position peaked at $68M in Q4 2022. 300 funds tracked by Wall St. Rank hold PRVA as of Q2 2026.

  • Israel Englander held 268,324 shares of Privia Health worth $6.9M as of Q2 2026.
  • Israel Englander sold 444,241 Privia Health shares in Q2 2026, an estimated $10.3M.
  • Privia Health made up ﹤0.01% of Israel Englander's portfolio in Q2 2026, its #2682 holding.
  • Israel Englander first reported a position in Privia Health in Q2 2021 and has held it in 21 quarters since.
  • Israel Englander's Privia Health position peaked at $68M in Q4 2022.
  • 300 funds tracked by Wall St. Rank held Privia Health as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.